[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4076 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 4076

 To authorize funding for a bilateral cooperative program with Israel 
              for the development of health technologies.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 13, 2023

 Mr. Pappas (for himself, Mr. Panetta, Ms. Salazar, Mr. Crenshaw, Mr. 
  Graves of Louisiana, Ms. Mace, Mr. Van Drew, Mr. Waltz, Mr. Nunn of 
Iowa, Mr. Fitzpatrick, Mr. Gimenez, Mr. Ezell, Mr. Dunn of Florida, Mr. 
 Moolenaar, Mr. Lawler, Mr. Lamborn, Mr. Mooney, Mr. Molinaro, Mr. Kim 
    of New Jersey, Mr. Davis of North Carolina, Mr. Ciscomani, Mr. 
Arrington, Mrs. McClain, Mr. Bacon, Mr. Gottheimer, Mr. Moskowitz, Mr. 
Auchincloss, Mr. Lieu, Mr. Schiff, Ms. Tokuda, Mr. Kilmer, Ms. Stevens, 
   Ms. Brownley, Mr. Sherman, Mr. Sorensen, Ms. Titus, Mr. Boyle of 
Pennsylvania, Mr. Levin, Mrs. Trahan, Ms. Meng, Mr. Mullin, Mr. Cohen, 
  Ms. Craig, Mr. Fleischmann, Mr. Kean of New Jersey, Mr. Steube, Mr. 
  Tony Gonzales of Texas, Mr. Bilirakis, Mr. Grothman, Mr. Bost, Mr. 
 Miller of Ohio, Mr. Rutherford, Ms. Brown, Mr. Turner, Mr. Johnson of 
South Dakota, Mr. Wilson of South Carolina, and Mr. Kustoff) introduced 
 the following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To authorize funding for a bilateral cooperative program with Israel 
              for the development of health technologies.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``United States-Israel Health 
Technologies Cooperation Act''.

SEC. 2. BILATERAL COOPERATIVE AGREEMENT.

    (a) Authorization of Appropriations.--There is authorized to be 
appropriated to the Secretary of Health and Human Services $4,000,000 
for each of fiscal years 2024 through 2026 for a bilateral cooperative 
program with the Government of Israel for awarding grants for the 
development of health technologies, including such technologies 
described in subsection (b), subject to subsection (c), with an 
emphasis on collaboratively advancing the use of technology, 
personalized medicine, and data in relation to emerging infectious 
diseases.
    (b) Types of Health Technologies.--The health technologies 
described in this subsection shall include technologies such as 
artificial intelligence, drugs and vaccinations, respiratory assist 
devices, diagnostic tests, and telemedicine.
    (c) Restrictions on Funding.--The funding under subsection (a) is 
subject to a matching contribution from the Government of Israel.
    (d) Option for Establishing New Program.--The amounts appropriated 
under subsection (a) may be--
            (1) for a bilateral program with the Government of Israel 
        that is in existence on the day before the date of enactment of 
        this Act for the purposes described in such subsection; or
            (2) for a bilateral program with the Government of Israel 
        that is established after the date of enactment of this Act by 
        the Secretary of Health and Human Services, in consultation 
        with the Secretary of State, in accordance with the Agreement 
        between the Government of the United States of America and the 
        Government of the State of Israel on Cooperation in Science and 
        Technology for Homeland Security Matters, done at Jerusalem May 
        29, 2008 (or a successor agreement), for the purposes described 
        in subsection (a).
                                 <all>